Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Growth Rate of the Esophageal Cancer Market?
There has been a robust growth in the market size for esophageal cancer in the last few years. The market that is predicted to be worth $1.39 billion in 2024 is expected to increase to $1.52 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 9.3%. Factors contributing to this growth during the historic period include a rise in cancer cases, enhancements in healthcare infrastructure, higher alcohol intake, an increase in the demand for preventative healthcare solutions and a higher occurrence of esophageal adenocarcinoma.
What Growth Rate Is Forecasted for the Esophageal Cancer Market by 2029?
The size of the esophageal cancer market is predicted to undergo substantial growth in the ensuing years, reaching $2.16 billion in 2029 with a compound annual growth rate (CAGR) of 9.3%. The projected expansion in the forecast period is due to the increasing rates of esophageal cancer, heightened public awareness on health matters, enhancement in healthcare infrastructure, chronic use of tobacco and alcohol, and increased cases of esophageal adenocarcinoma. Key trends anticipated during the forecast period encompass advancements in treatment alternatives, expanded investment in research and development, rising use of precision medicine, the advent of targeted therapies, increased involvement in clinical trials, and collaborations among academia, pharmaceutical corporations, and healthcare institutions.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12637&type=smp
Which Key Companies Are Shaping the Future of the Esophageal Cancer Market?
Major companies operating in the esophageal cancer market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc, AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Servier Pharmaceuticals, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Ipsen SA, Dr. Reddy’s Laboratories Ltd., Seagen Inc., Exelixis Inc., BeiGene Ltd., Clovis Oncology Inc., Aslan Pharmaceuticals Ltd.
Which Factors Are Driving Demand in the Esophageal Cancer Industry?
The esophageal cancer market is anticipated to grow due to an expected rise in esophageal cancer rates. Esophageal cancer malignantly affects the esophagus, the pipe-like structure which connects the throat and the stomach. As the occurrence of this cancer multiplies, there will be an amplified demand for diagnostic processes such as endoscopy, imaging tests, and biopsies that can identify and affirm the disease’s presence. For example, the American Cancer Society, a professional organization based in the US, reported 16,120 new deaths due to esophageal cancer in 2023 and anticipates the figure to increase to 16,130 by 2024. Therefore, the rise in esophageal cancer cases is anticipated to propel the esophageal cancer market’s growth.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=12637&type=smp
How Is the Esophageal Cancer Market Segmented by Several Divisions?
The esophageal cancer market covered in this report is segmented –
1) By Type: Esophageal Squamous-Cell Carcinoma, Esophageal Adenocarcinoma, Other Types
2) By Treatment Type: Chemotherapy, Targeted Therapy, Other Treatment Types
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End Users: Hospitals, Homecare, Specialty Centers, Other End Users
Subsegments:
1) By Esophageal Squamous-Cell Carcinoma: Localized Squamous-Cell Carcinoma, Advanced Squamous-Cell Carcinoma
2) By Esophageal Adenocarcinoma: Localized Adenocarcinoma, Advanced Adenocarcinoma
3) By Other Types: Neuroendocrine Tumors, Sarcomas, Mixed Cell Type Carcinomas
What are the Emerging Market Trends Driving the Growth of the Esophageal Cancer Industry?
The esophageal cancer market is seeing the trend of new drug approval growing in prominence. To gain a competitive edge and fortify their market position, leading companies in the market are putting major emphasis on securing approval for new drugs. For instance, Bristol Myers Squibb, a pharmaceutical firm from the US, got the green light from the U.S. Food and Drug Administration (FDA) for two of its products, Opdivo (nivolumab) intended for intravenous use and ipilimumab branded as Opdivo plus Yervoy, in May 2022. The focus of these therapeutic strategies is on those diagnosed with advanced or metastatic esophageal squamous cell carcinoma (ESCC). The licensing happened post a Phase 3 clinical trial assessment which exhibited increased survival rates in patients administered these drugs.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/esophageal-cancer-global-market-report
Which Regions Are Driving Growth in the Esophageal Cancer Market?
North America was the largest region in the esophageal cancer market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the esophageal cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12637
This Report Delivers Insight On:
1. How big is the esophageal cancer market, and how is it changing globally?
2. Who are the major companies in the esophageal cancer market, and how are they performing?
3. What are the key opportunities and risks in the esophageal cancer market right now?
4. Which products or customer segments are growing the most in the esophageal cancer market?
5. What factors are helping or slowing down the growth of the esophageal cancer market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
